Bristol-Myers wins $752 million in U.S. patent case against Gilead

Bristol-Myers wins $752 million in U.S. patent case against Gilead

Submitted by admin on December 13, 2019 - 9:09pm
Source: 
Reuters
News Tags: 
Bristol-Myers Squibb
Gilead Sciences
Kite Pharma
patents
Juno Therapeutics
Headline: 
Bristol-Myers wins $752 million in U.S. patent case against Gilead
snippet: 

Bristol-Myers Squibb Co on Friday said it won a $752 million jury verdict against Gilead Sciences Inc in a U.S. patent dispute relating to technology for treating cancer.

Do Not Allow Advertisers to Use My Personal information